Background and present status of research on platelet-activating factor (PAF-acether).
about
Isolation of a platelet membrane protein which binds the platelet-activating factor 1-0-hexadecyl-2-acetyl-SN-glycero-3-phosphorylcholineInflammatory actions of platelet activating factor (Pafacether) in guinea-pig skinTime course of PAF formation by gastrointestinal tissue in rats after castor oil challengeSynthesis of plasmalogens in eye lens epithelial cellsPOSTER COMMUNICATIONSHistamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acetherThe platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotrieneImproved hepatic function in the 24-hour preserved rat liver with UW-lactobionate solution and SRI 63-441Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor.Effects of PAF on excitatory neuro-effector transmission in dog airwaysPlatelet-activating factor relaxes ferret tracheal smooth muscle and reduces transepithelial potential difference in vitro.Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC)Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.Glucocorticoid protection against PAF-acether toxicity in mice.Platelet activating factor raises intracellular calcium ion concentration in macrophages.Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factorCan the synthesis of platelet-activating factor, a potent vasodilator and pro-aggregatory agent, be altered by dietary marine oils?Platelet activating factor stimulates secretion of mucin by explants of rodent airways in organ culture.In vivo platelet aggregation in the rat: dependence on extracellular divalent cation and inhibition by nonsteroidal anti-inflammatory drugsExperimental Trypanosoma cruzi cardiomyopathy in BALB/c mice. The potential role of intravascular platelet aggregation in its genesis.Gastric mucosal damage induced by local intra-arterial administration of Paf in the ratInteraction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors.Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity.Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis.Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.A comparative study of endothelin- and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells.Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists.Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked.Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms.Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis.Effects of BN 52063 and other agents inhibiting platelet-activating factor-induced contractile responses in rat portal vein.Calmodulin antagonists inhibit aggregation of human, guniea pig and rabbit platelets induced with platelet activating factor.Time-dependent Increase of Platelet-activating Factor Acetylhydrolase in the Culture Medium of Mouse Calvaria.Platelet activating factor stimulates rapid mucin secretion in rat nasal airways in vivo.
P2860
Q24545617-A62429DF-6D6A-485C-A084-D0160637F1B7Q24672250-4FC6BD88-24C3-4118-976B-136198C20053Q28327658-26ED6AD9-9A27-457A-8D62-7D27131A3221Q28592562-91DD1B11-9561-4077-8FB4-4ED48B245525Q29031985-BB09AC4B-9FC5-46FC-8F93-4F2F2B8512B2Q33459605-3C3F7685-EA67-447D-A8EB-EF307A1985D0Q33478300-5F1C98B9-C5EE-4942-8722-4A01E7E6149DQ34434464-447BA207-F963-42C0-9015-0A4BDFFE186DQ35587409-192D6148-1654-47D1-B593-AA94877321ACQ35807925-80BA4ABD-A78E-494F-8C7F-1B79C91D05DAQ35871365-C0A8D2B0-8D10-4E61-A39D-4DCF94DAAE29Q35872339-20100BB6-A4C2-4442-B0B6-4DFA9B496584Q35885732-386FE074-262C-4DE8-832F-601FF7B693FAQ36004051-263986FC-9CA9-4CEB-9ADC-5DC4C15EF96DQ36097813-4D52B2E4-D1D5-4313-B329-C23C1C2D68D0Q36213127-32EFC90B-C5CB-4C14-8034-16D805804285Q36357510-689C4DCD-9D39-4B72-BBCA-7ACAE10DC941Q41332562-0AB783FE-5F23-4F53-B341-5124AA3947A8Q41463257-31E03946-E449-490C-A23F-96E86D7AA429Q41744711-2E973211-1611-4885-85AF-C83F51CF8CE1Q41808146-DCE636C0-56DE-4ED5-B08E-B7773A5F1117Q41824010-1E4C5361-CD7B-4276-B61C-3CAD8C63F413Q41906314-A681A24A-9A94-4C2D-B133-12E20B0A890CQ41977554-EE7C6219-95A6-45CC-982F-A76D861E89CCQ42018117-A37B57DA-EA3E-43CF-9315-2A58E75F3A30Q42051045-5EC350C1-B3E9-44F1-820E-91561821526DQ42075404-7B981D68-ADAD-4901-A6C3-ECD8A50AD1C7Q42226119-64C568A8-B7B0-4B19-AAB3-F40805835C56Q42544910-970FBB5C-C2F5-4FC3-A42D-C419A09459F0Q42792724-9031A1DE-8070-4003-8084-CFDFE63B08B6Q42848062-0ADD46FA-EAAA-493F-B3E4-EB2D77A94037Q42848383-0AF1BCB1-CA00-4429-A8F5-EA00EDAA9FAAQ42849846-BFB285D5-3D97-4DEC-A1AB-6D618CD85396Q42850005-A462946C-15DB-42E8-8A60-C58073A2DB5BQ42854996-DC32462E-4E14-4F88-B1EF-ADB770EE4372Q43185671-C4B49853-8FC5-486B-9E7D-074BCF63DF74Q43871882-9F2BBB1A-1E4A-4098-A1AD-815437AD3936Q46681856-740A80BF-26DA-461F-A851-C7E1ACF7B3E5Q47776568-97DEA607-D202-4399-85A1-B774B2C00805Q50780040-432E0BC3-5063-46F3-B806-21E29D4EAF7C
P2860
Background and present status of research on platelet-activating factor (PAF-acether).
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Background and present status of research on platelet-activating factor (PAF-acether).
@en
type
label
Background and present status of research on platelet-activating factor (PAF-acether).
@en
prefLabel
Background and present status of research on platelet-activating factor (PAF-acether).
@en
P2093
P2860
P1476
Background and present status of research on platelet-activating factor (PAF-acether).
@en
P2093
P2860
P304
P356
10.1111/J.1749-6632.1981.TB29727.X
P407
P577
1981-01-01T00:00:00Z